Concepedia

Publication | Open Access

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention

170

Citations

24

References

2017

Year

Abstract

clinicaltrials.gov Identifier: NCT02163993.

References

YearCitations

Page 1